Facebook
Twitter
LinkedIn
Forward
Critical Challenges and Compelling Questions for COPD
Chronic Obstructive Pulmonary Disease (COPD) is the third-leading cause of death in the United States. Despite its significant impact on the World’s population, mush about the disease remains poorly understood. Further research is crucial to inform healthcare providers about pathogenesis, risk factors, and better therapeutic approaches. This session will identify gaps in our current knowledge base, describe recent progress in the field of COPD research, and outline strategies to help answer compelling questions relevant to this disease.
This course is an edited and enhanced recording of the ATS 2022 International Conference session with the same name.
Grant Support: This educational module is supported by an independent medical educational grant from AstraZeneca LP.
Target Audience
Clinicians (physicians, nurses, fellows, residents), researchers, administrators, and policymakers: anyone involved in the delivery of care and the science of patients with COPD
Learning Objectives
After successfully completing this module, learners will be able to:
• Discuss novel concepts in disease pathogenesis, health disparities, and therapeutic strategies
• Identify critical areas of future COPD research priorities for the upcoming decade
• Describe the challenges for optimal implementation of COPD research in an effort to impact local and national treatment outcomes
| Name | Title | Institution | Role | Relationship |
| Ravi Kalhan, MD, MS. | Director, Asthma and COPD Program | Northwestern University Feinberg School of Medicine | Presenter | GlaxoSmithKline: Advisory Committee for promotional purpose AstraZeneca: Advisory Committee for promotional purpose CVS Caremark: Consultant |
| Michael Bradley Drummond, MHS, MD, ATSF | Associate Professor of Medicine | The University of North Carolina at Chapel Hill | Presenter | Verona: Consultant Boehringer Ingelheim: Consultant; Research - investigator initiated Teva: Consultant; Research - investigator initiated Midmark: Consultant; Research - investigator initiated Optimum: Consultant GlaxoSmithKline: Consultant Polarean: Consultant National Institutes of Health: Research - investigator initiated |
| Christine M. Freeman, PhD | Assistant Research Professor | University of Michigan, Ann Arbor | Presenter | NONE |
| Stefanie Krick, MD, PhD | Assistant Professor, Division of Pulmonary, Allergy and Critical Care Medicine | University of Alabama at Birmingham | Presenter | NONE |
| Lisa Postow, PhD | Program Director, National Heart, Lung, and Blood Institute | National Institutes of Health | Presenter | NONE |
Accreditation Statement
The American Thoracic Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Disclosure Declaration
It is the policy of the ATS to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. As an accredited CME provider, the ATS requires that its planners, reviewers and presenters comply with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. The ATS also requires specific disclosure of relationships with companies and organizations associated with tobacco or cannabis and prohibits or limits participation of faculty in official ATS activities, including CME, if any tobacco industry relationship or some types of cannabis industry relationships are present. To see the most recent policies regarding potential conflicts of interest as well as the mechanisms to resolve such conflicts, press the COI Policy link below.
This educational activity may include discussion of unapproved uses of a drug, product, or device. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Instructions to Receive Credit
To earn credit for this course, follow these instructions:
- Launch and complete all modules by viewing every page in the module.
- After you complete the module(s), the post test will become available. You must pass the post these with a 70% score or better.
- Complete the Course Evaluation.
- Once you complete the modules, pass the post test and complete the evaluation, the system will grant you credit.
- To view your transcript and print your certificate, go to the My Account drop-down list. Then select Transcript.
Available Credit
- 1.50 AMA PRA Category 1 Credit(s)™The American Thoracic Society designates this for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.50 Participation